A case of desensitization, transplantation, and allograft dysfunction

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1573-1581

  Magee, Colm ^a   Clarkson, Michael ^b   Rennke, Helmut ^c  

^a BEAUMONT HOSPITAL   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOTRANSPLANTATION; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; CLINICAL STUDY; CONFERENCE PAPER; DESENSITIZATION; DIAGNOSIS; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LIVING DONOR; PATHOLOGY; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; REOPERATION; RISK ASSESSMENT; TREATMENT FAILURE;

ADULT; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS; RENAL DIALYSIS; REOPERATION; RISK ASSESSMENT; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 53749098689     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00920208     Document Type: Conference Paper

References (25)

1. Pollinger HS, Stegall MD, Gloor JM, Moore SB, Degoey SR, Ploeger NA, Park WD, Pollinger HS, Stegall MD, Gloor JM, Moore SB, Degoey SR, Ploeger NA, Park WD: Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 7: 857-863, 2007
2. Zou Y, Stastny P, Süsal C, Döhler B, Opelz G: Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 357: 1293-1300, 2007
3. Magee CC: Transplantation across previously incompatible immunological barriers. Transpl Int 19: 87-97, 2006
4. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8: 753-760, 2008
5. Venetz JP, Pascual M: New treatments for acute humoral rejection of kidney allografts. Expert Opin Investig Drugs 16: 625-633, 2007
6. Glotz D, Antoine C, Julia P, Suberbielle-Boissel C, Boudjeltia S, Fraoui R, Hacen C, Duboust A, Bariety J: Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2: 758-760, 2002
7. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J: Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15: 3256-3262, 2004
8. Jordan SC, Vo A, Bunnapradist S, Toyoda M, Peng A, Puliyanda D, Kamil E, Tyan D: Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 76: 631-636, 2003
9. Jordan S, Cunningham-Rundles C, McEwan R: Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 3: 653-664, 2003
10. Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, Larson TS, Griffin MD, Textor SC, Velosa JA, Schwab TR, Fix LA, Stegall MD: Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 3: 1017-1023, 2003
11. Montgomery RA, Zachary AA: Transplanting patients with a positive donor-specific crossmatch: a single center's perspective. Pediatr Transplant 8: 535-542, 2004
12. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70: 887-895, 2000
13. Schweitzer EJ, Wilson JS, Fernandez-Vina M, Fox M, Gutierrez M, Wiland A, Hunter J, Farney A, Philosophe B, Colonna J, Jarrell BE, Bartlett ST: A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 70: 1531-1536, 2000
14. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S: A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 6: 346-351, 2006
15. Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS, Fotino M, Friedlander R: Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients. Transplantation 76: 1444-1447, 2003
16. Gloor JM, DeGoey S, Ploeger N, Gebel H, Bray R, Moore SB, Dean PG, Stegall MD: Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 78: 221-227, 2004
17. Magee CC: Renal transplantation in patients with positive lymphocytoxicity crossmatches: one center's experience. Transplantation 2008, in press
18. Setoguchi K, Ishida H, Shimmura H, Shimizu T, Shirakawa H, Omoto K, Toki D, Iida S, Setoguchi S, Tokumoto T, Horita S, Nakayama H, Yamaguchi Y, Tanabe K: Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant 8: 86-94, 2008
19. Bearden CM, Agarwal A, Book BK, Sidner RA, Gebel HM, Bray RA, Pescovitz MD: Pronase treatment facilitates alloantibody flow cytometric and cytotoxic cross-matching in the presence of rituximab. Hum Immunol 65: 803-809, 2004
20. Gloor JM, Moore SB, Schneider BA, Degoey SR, Stegall MD: The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays. Transplantation 84: 258-264, 2007
21. Montgomery RA, Hardy MA, Jordan SC, Racusen LC, Ratner LE, Tyan DB, Zachary AA; Antibody Working Group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols: Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation 78: 181-185, 2004
22. Bohmig GA, Wahrmann M, Regele H, Exner M, Robl B, Derfler K, Soliman T, Bauer P, Müllner M, Druml W: Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Am J Transplant 7: 117-121, 2007
23. Kaplan B, Gangemi A, Thielke J, Oberholzer J, Sankary H, Benedetti E: Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Transplantation 83: 99-100, 2007
24. Zachary AA, Montgomery RA, Leffell MS: Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 66: 364-370, 2005
25. Terasaki PI, Ozawa M: Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 4: 438-443, 2004